A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

NCT03811652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
Head and Neck Squamous Cell Carcinoma (HNSCC)
Small Cell Lung Cancer (SCLC)
Pancreatic Ductal Adenocarcinoma (PDAC)
Colorectal Cancer (CRC)
Metastatic Castration-resistant Prostate Cancer (mCRPC)

Interventions

DRUG: MEDI7247

Sponsor

MedImmune LLC